Secretariat office for the 74th Annual Meeting of the Japanese Society of Hematology
c/o Congress Corporation
Kohsai-kaikan Bldg., 5-1 Kojimachi, Chiyoda-ku, Tokyo 102-8481
Tel:+81-3-5216-5318
Fax:+81-3-5216-5552
E-mail:jsh2012@congre.co.jp
These Programs are presented in English.
19-Oct（Fri）12：10−13：00
| CS-1 | The choice of stem cell source for unrelated SCT | 【No.2 Annex 1】 |
- Chair
- Kimikazu Matsumoto（Japanese Red Cross Nagoya Daiichi Hospital, Japan）
- Speaker
- Claudio Anasetti（Department of Blood and Marrow Transplantation, Moffitt Cancer Center, USA）
- Sponsor
- CHUGAI PHARMACEUTICAL CO., LTD.
| CS-6 | Latest topics of Indolent NHL treatment, including radioimmunotherapy |
| 【No.7 Room C-1】 |
- Chair
- Kensei Tobinai（National Cancer Center Hospital, Japan）
- Speaker
- Anton Hagenbeek（Department of Hematology, University Medical Center Utrecht, The Netherlands）
- Sponsor
- FUJIFILM RI Pharma Co., Ltd. / Spectrum Pharmaceuticals Inc.
| CS-7 | The latest topics of PNH management in the era of Eculizumab |
| 【No.8 Room C-2】 |
- Chair
- Yuzuru Kanakura（Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Japan）
- Speaker
- Peter Hillmen（Leeds Teaching Hospitals NHS Trust, Leeds, UK）
- Sponsor
- Alexion Pharma GK
| CS-12 | Novel Targeted Therapies of Multiple Myeloma |
| 【Corporate Seminar Room Grand Prince Hotel Kyoto Royal Room】 |
- Chair
- Shinichiro Okamoto（Keio University School of Medicine, Division of Hematology, Department of Internal Medicine, Japan）
- Speaker
- Kenneth C. Anderson（Jerome Lipper Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, USA）
- Sponsor
- Celgene K.K.
20-Oct（Sat）12：10−13：00
| CS-14 | Biology and Treatment: EBV-associated lymphoma | 【No.2 Annex 1】 |
- Chair
- Tomomitsu Hotta（National Cancer Center, Japan）
- Speaker
- Wyndham Wilson（National Cancer Institute, USA）
- Sponsor
- CHUGAI PHARMACEUTICAL CO., LTD.
| CS-15 | Treatment Strategy for Newly Diagnosed Multiple Myeloma | 【No.3 Annex 2】 |
- Chair
- Kazuyuki Shimizu（Aichigakuin University Dental Hospital, Japan）
- Speaker
- Sagar Lonial（Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, USA）
- Sponsor
- JANSSEN PHARMACEUTICAL K.K. / Takeda Pharmaceutical Company Limited
| CS-21 | Advances in the therapy of myeloid neoplasms | 【No.9 Room D】 |
- Chair
- Kinuko Mitani（Dokkyo Medical University School of Medicine, Department of Hematology and Oncology, Japan）
- Speaker
- Farhad Ravandi-Kashani（Department of Leukemia, The University of Texas-MD Anderson Cancer Center, Japan）
- Sponsor
- Celgene K.K.
21-Oct（Sun）12：10−13：00
| CS-35 |
The role of thalidomide in induction, consolidation, and maintenance of myeloma |
| 【Corporate Seminar Room Swan】 |
- Chair
- Yutaka Hattori（Keio University Faculty of Pharmacy, Japan）
- Speaker
- Gareth J, Morgan（Sections of Haemato-Oncology Research Unit, Division of Molecular Pathology, Institute of Cancer Research, and the Royal Marsden National Health Service, UK）
- Sponsor
- Fujimoto Pharmaceutical Corporation